Murray Skinner

908 total citations
43 papers, 650 citations indexed

About

Murray Skinner is a scholar working on Immunology and Allergy, Dermatology and Physiology. According to data from OpenAlex, Murray Skinner has authored 43 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology and Allergy, 19 papers in Dermatology and 13 papers in Physiology. Recurrent topics in Murray Skinner's work include Allergic Rhinitis and Sensitization (28 papers), Food Allergy and Anaphylaxis Research (18 papers) and Dermatology and Skin Diseases (16 papers). Murray Skinner is often cited by papers focused on Allergic Rhinitis and Sensitization (28 papers), Food Allergy and Anaphylaxis Research (18 papers) and Dermatology and Skin Diseases (16 papers). Murray Skinner collaborates with scholars based in United Kingdom, Switzerland and Germany. Murray Skinner's co-authors include Matthew D. Heath, Matthias Krämer, Martin F. Bachmann, Mona O. Mohsen, Thomas M. Kündig, Gustavo Cabral‐Miranda, Ludger Klimek, Paul Engeroff, Carsten B. Schmidt‐Weber and Andris Zeltiņš and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Murray Skinner

38 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray Skinner United Kingdom 16 377 241 186 142 93 43 650
Kimberly O’Brien United States 8 178 0.5× 167 0.7× 45 0.2× 160 1.1× 86 0.9× 10 511
R.J. Dilworth Australia 7 654 1.7× 250 1.0× 226 1.2× 66 0.5× 77 0.8× 8 797
K.Y. Chua Australia 23 1.4k 3.8× 515 2.1× 511 2.7× 114 0.8× 147 1.6× 35 1.7k
Steven A. Dunham United States 9 103 0.3× 57 0.2× 160 0.9× 75 0.5× 253 2.7× 11 630
Ina Baļķe Latvia 12 100 0.3× 44 0.2× 14 0.1× 112 0.8× 128 1.4× 26 484
Yvette M. Schlotter Netherlands 10 83 0.2× 42 0.2× 155 0.8× 59 0.4× 75 0.8× 13 302
Egil Olsen Canada 11 175 0.5× 37 0.2× 60 0.3× 32 0.2× 102 1.1× 18 368
Aleksandra Inić‐Kanada Serbia 15 30 0.1× 31 0.1× 19 0.1× 169 1.2× 116 1.2× 52 529
C M Bozic United States 10 124 0.3× 39 0.2× 58 0.3× 44 0.3× 124 1.3× 11 421
B L Elder United States 7 27 0.1× 48 0.2× 11 0.1× 41 0.3× 125 1.3× 16 324

Countries citing papers authored by Murray Skinner

Since Specialization
Citations

This map shows the geographic impact of Murray Skinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Skinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Skinner more than expected).

Fields of papers citing papers by Murray Skinner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray Skinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Skinner. The network helps show where Murray Skinner may publish in the future.

Co-authorship network of co-authors of Murray Skinner

This figure shows the co-authorship network connecting the top 25 collaborators of Murray Skinner. A scholar is included among the top collaborators of Murray Skinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray Skinner. Murray Skinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pfaar, Oliver, Ralph Mösges, Michael S. Blaiss, et al.. (2025). The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach. Allergy. 80(12). 3369–3376.
3.
Layhadi, Janice A., Pieter‐Jan de Kam, Elizabeth Palmer, et al.. (2025). Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals. Journal of Allergy and Clinical Immunology. 155(1). 153–165. 2 indexed citations
4.
Zielen, Stefan, Jonathan A. Bernstein, Gunter J. Sturm, et al.. (2025). Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial. Allergy. 80(7). 1982–1994. 2 indexed citations
5.
Heath, Matthew D., et al.. (2024). Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy. Clinical & Experimental Allergy. 54(2). 130–142. 3 indexed citations
6.
Sobczak, Jan M., Ina Baļķe, Murray Skinner, et al.. (2023). Influence of antigen density and TLR ligands on preclinical efficacy of a VLP‐based vaccine against peanut allergy. Allergy. 79(1). 184–199. 13 indexed citations
7.
Kam, Pieter‐Jan de, Matthias Krämer, Mohamed H. Shamji, et al.. (2021). Dogmas, challenges, and promises in phase III allergen immunotherapy studies. World Allergy Organization Journal. 14(9). 100578–100578. 5 indexed citations
8.
Heath, Matthew D., Mona O. Mohsen, Pieter‐Jan de Kam, et al.. (2020). Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in Immunology. 11. 594911–594911. 18 indexed citations
9.
Mohsen, Mona O., Matthew D. Heath, Gustavo Cabral‐Miranda, et al.. (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for ImmunoTherapy of Cancer. 7(1). 114–114. 51 indexed citations
10.
Zielen, Stefan, Piotr Kuna, Werner Aberer, et al.. (2019). Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing. World Allergy Organization Journal. 12(11). 100075–100075. 13 indexed citations
11.
Heath, Matthew D., et al.. (2019). Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy. World Allergy Organization Journal. 12(11). 100087–100087. 10 indexed citations
12.
Storni, Federico, Andris Zeltiņš, Ina Baļķe, et al.. (2019). Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. Journal of Allergy and Clinical Immunology. 145(4). 1240–1253.e3. 77 indexed citations
13.
Freiberger, Sandra N., Gabriele Fenini, Emmanuel Contassot, et al.. (2018). Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling. The Journal of Immunology. 200(9). 3151–3159. 44 indexed citations
14.
Worm, Margitta, T. W. Higenbottam, Oliver Pfaar, et al.. (2018). Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy. Allergy. 73(9). 1812–1822. 25 indexed citations
15.
Bell, Andrew, et al.. (2017). Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities. World Allergy Organization Journal. 10(1). 17–17. 11 indexed citations
16.
17.
18.
Skinner, Murray, et al.. (2011). A Proteomic Style Approach To Characterize a Grass Mix Product Reveals Potential Immunotherapeutic Benefit. SHILAP Revista de lepidopterología. 4(9). 140–146. 3 indexed citations
19.
Martin, Stephen R., Rodolfo R. Biekofsky, Murray Skinner, et al.. (2004). Interaction of calmodulin with the phosphofructokinase target sequence. FEBS Letters. 577(1-2). 284–288. 15 indexed citations
20.
Skinner, Murray, et al.. (1994). Deletion of fowlpox virus homologues of vaccinia virus genes between the 3beta-hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes. Journal of General Virology. 75(9). 2495–2498. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly O’Brien Breakdown of academic impact, for papers by R.J. Dilworth Breakdown of academic impact, for papers by K.Y. Chua Breakdown of academic impact, for papers by Steven A. Dunham Breakdown of academic impact, for papers by Ina Baļķe Breakdown of academic impact, for papers by Yvette M. Schlotter Breakdown of academic impact, for papers by Egil Olsen Breakdown of academic impact, for papers by Aleksandra Inić‐Kanada Breakdown of academic impact, for papers by C M Bozic Breakdown of academic impact, for papers by B L Elder
Rankless by CCL
2026